AVYCAZ: payments to doctors
Payments that named AVYCAZ as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $4.7M
- Providers
- 19,591
- Transactions
- 72,335
- Average per transaction
- $65
The per-transaction average — $65 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 19,591 providers the average total is $241, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| AbbVie | $4,725,060 | 100.0% |